Cargando…
Serotonin receptor subtype-2B signaling is associated with interleukin-18-induced cardiomyoblast hypertrophy in vitro
BACKGROUND: In patients with heart failure, interleukin-18 (IL-18) levels increase in the circulatory system and injured myocardial tissue. Serotonin (5-hydroxytryptamine) receptors subtype 2B (HTR2B) play an essential role in cardiac function and development, and their overexpression in rats leads...
Autores principales: | Chen, Chao-Yi, Leu, Jyh-Gang, Lin, Kuan-Yu, Shih, Chin-Yu, Liang, Yao-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321165/ https://www.ncbi.nlm.nih.gov/pubmed/37551283 http://dx.doi.org/10.2478/abm-2022-0010 |
Ejemplares similares
-
Interleukin-18 deteriorates Fabry cardiomyopathy and contributes to the development of left ventricular hypertrophy in Fabry patients with GLA IVS4+919 G>A mutation
por: Chien, Yueh, et al.
Publicado: (2016) -
Molecular dissection of cardiac hypertrophy induced by interleukin-18
por: Majumdar, Sirshendu, et al.
Publicado: (2009) -
EGFR activation triggers cellular hypertrophy and lysosomal disease in NAGLU-depleted cardiomyoblasts, mimicking the hallmarks of mucopolysaccharidosis IIIB
por: De Pasquale, Valeria, et al.
Publicado: (2018) -
The Serotonin Receptor Subtype 5b Specifically Interacts with Serotonin Receptor Subtype 1A
por: Niebert, Sabine, et al.
Publicado: (2017) -
Protective Effects of Nanoceria against Mitochondrial Dysfunction and Angiotensin II-Induced Hypertrophy in H9c2 Cardiomyoblasts
por: Gul, Rukhsana, et al.
Publicado: (2023)